Caduceus Biotechnology Inc. focuses on advanced biomedical imaging products for in vitro diagnostics to improve medical diagnosis accuracy and efficiency. To accelerate development and meet clinical demands, Caduceus has allied with National Cheng Kung University in Taiwan. This collaboration integrates technology and resources while exchanging knowledge and expertise. The parties will explore advanced technologies in biomedical imaging, focusing on AI applications. Caduceus has joined the Industrial Innovation Application Alliance for Advanced Biomedical Imaging and Clinical AI Value-Added Services, which aims to promote industry innovation, development, and provide efficient medical solutions.
The alliance accelerates technology application, offering medical professionals tools to enhance diagnostic accuracy and personalize treatment, ultimately improving medical services for patients. By combining National Cheng Kung University's research capabilities with Cheng Kung University Hospital's clinical expertise, we aim to quickly apply our technology to the public. This collaboration integrates academic research with medical practice to foster innovative technologies and accelerate their practical application.
National Cheng Kung University offers advanced research resources and a committed team exploring cutting-edge technologies, while Cheng Kung University Hospital provides extensive clinical experience, offering feedback for practical technology application. This collaboration ensures our technology is validated in labs and tested in real-world settings, ensuring safety and effectiveness.
Our ultimate goal is to improve health, enhance quality of life, and contribute to societal progress by bringing these technologies to everyone. We anticipate the positive outcomes and wider benefits of this collaboration.
Comments